Hot News
RNS: Over 3131.84 MTs of Liquid Medical oxygen (LMO) were supplied by different public and private steel units to various …
Steel units supplies over 3131.84 MT LMO to many states: Ministry of Steel Read More
RNS: SAIL’s Bokaro Steel Plant (BSL) overcame the unprecedented challenges and hurdles posed by the pandemic to set several new …
BSL overcomes challenges of COVID-19, sets new records in FY 2020-21 Read More
RNS: A Memorandum of understanding (MoU) was signed on “Technology development for holistic utilization of red mud for extraction of …
CSIR signs ‘Technology Agreement’ with Aluminium Industries Read More
RNS: Vedanta has recycled 282.65 million cubic metres of water for the past four years as part of its philosophy …
Vedanta opts latest technologies for water conservation; Reuses 282.65 million cubic metres of water Read More
Bokaro: Steel Authority of India Limited (SAIL)’s Bokaro Steel Plant (BSL) continues to make inroads in the export market. Eyeing …
Eyeing on European market, BSL exports HR coils to Italy Read More
Geneva: The World Health Organization (WHO) has approved the emergency use of Corona vaccine manufactured by Johnson & Johnson’s— a …
WHO approves Johnson & Johnson’s Corona Vaccine for emergency use Read More
Bengaluru: Indian Space Research Organisation (ISRO) launched the sounding rocket, RH-560 to study attitudinal variations in neutral winds and plasma …
ISRO launches sounding rocket to study attitudinal variations in the neutral winds and plasma dynamics Read More
Ladakh: CyberPeace Foundation, a think tank and grassroots NGO of cybersecurity and policy experts launched the third phase of the …
CyberPeace Foundation launches Digital Shakti 3.0 in Leh, Ladakh Read More
Jamshedpur: CSIR-NML transferred e-waste recycling technologies to a Kolkata-based firm M/s Metaore Recycling Private Ltd., on Friday. Metaore recycling plant …
CSIR-NML transfers e-waste recycling technologies to Kolkata based firm Read More
RNS: India’s first indigenous developed coronavirus vaccine, COVAXIN, has demonstrated an interim vaccine efficacy of 81 percent in Phase 3 …
India’s COVAXIN shows 81 per cent efficacy Read More